Interleukin 2 (IL2) PE40 is cytotoxic to cells displaying either the p55 or p70 subunit of the IL2 receptor. 1988

H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892.

IL2-PE40 is a chimeric protein composed of human interleukin 2 (IL2) genetically fused to the amino terminus of a modified form of pseudomonas exotoxin (PE). Internalization of IL2 via the individual p55 and p70 subunits of the IL2 receptor was studied using IL2-PE40 on several mouse and human cell lines expressing either the p55, the p70, or both IL2 receptor subunits. Internalization was assessed by measuring inhibition of protein synthesis caused by the toxin moiety of IL2-PE40. The results demonstrate that IL2 internalization is mediated by either the p55 receptor subunit or by the p70 subunit but is much more efficient when high affinity receptors composed of both subunits are present. IL2-PE40 is a powerful reagent for studying IL2 receptor interactions and for analyzing pathways of the immune response and its regulation.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005098 Exotoxins Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. Exotoxin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097668 Pseudomonas aeruginosa Exotoxin A An NAD-dependent ADP-ribosyltransferase that catalyzes the transfer of the ADP ribosyl moiety of oxidized NAD onto elongation factor 2 (EF-2) thus arresting protein synthesis. Commonly used as the toxin in immunotoxins. Exotoxin A, Pseudomonas,Exotoxin A, Pseudomonas aeruginosa,Recombinant Truncated Pseudomonas Exotoxin A, Form PE38QQR,Recombinant Truncated Pseudomonas Exotoxin A, Form PE40,ToxA protein, Pseudomonas aeruginosa,ETA, Pseudomonas,PE38QQR,PE40 toxin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
October 1989, Biochemical and biophysical research communications,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
April 1995, Archives of biochemistry and biophysics,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
August 1990, Biochemical and biophysical research communications,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
January 1995, Bioconjugate chemistry,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
October 1987, The Journal of experimental medicine,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
February 1993, Transplantation proceedings,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
October 1988, Proceedings of the National Academy of Sciences of the United States of America,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
January 2008, The Journal of biological chemistry,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
July 1987, European journal of immunology,
H Lorberboum-Galski, and R W Kozak, and T A Waldmann, and P Bailon, and D J FitzGerald, and I Pastan
November 1988, The Journal of experimental medicine,
Copied contents to your clipboard!